BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33480428)

  • 1. Changes in pulmonary function and their correlation with dose-volume parameters in patients undergoing stereotactic body radiotherapy for lung cancer.
    Takemoto S; Shibamoto Y; Hashizume C; Miyakawa A; Murai T; Yanagi T; Sugie C; Nagai A
    J Radiat Res; 2021 Mar; 62(2):338-345. PubMed ID: 33480428
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lack of a dose-effect relationship for pulmonary function changes after stereotactic body radiation therapy for early-stage non-small cell lung cancer.
    Guckenberger M; Klement RJ; Kestin LL; Hope AJ; Belderbos J; Werner-Wasik M; Yan D; Sonke JJ; Bissonnette JP; Xiao Y; Grills IS
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):1074-81. PubMed ID: 23154077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary function changes following helical tomotherapy in patients with inoperable, locally advanced non-small cell lung cancer.
    Vekens K; Verbanck S; Collen C; Storme G; Barbé K; De Ridder M; Vanderhelst E
    Strahlenther Onkol; 2020 Feb; 196(2):142-150. PubMed ID: 31300831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in Pulmonary Function Following Image-Guided Stereotactic Lung Radiotherapy: Neither Lower Baseline Nor Post-SBRT Pulmonary Function Are Associated with Worse Overall Survival.
    Stone B; Mangona VS; Johnson MD; Ye H; Grills IS
    J Thorac Oncol; 2015 Dec; 10(12):1762-9. PubMed ID: 26334751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary function following high-dose radiotherapy of non-small-cell lung cancer.
    De Jaeger K; Seppenwoolde Y; Boersma LJ; Muller SH; Baas P; Belderbos JS; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2003 Apr; 55(5):1331-40. PubMed ID: 12654445
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Physical and biological predictors of changes in whole-lung function following thoracic irradiation.
    Marks LB; Munley MT; Bentel GC; Zhou SM; Hollis D; Scarfone C; Sibley GS; Kong FM; Jirtle R; Jaszczak R; Coleman RE; Tapson V; Anscher M
    Int J Radiat Oncol Biol Phys; 1997 Oct; 39(3):563-70. PubMed ID: 9336133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Poor baseline pulmonary function may not increase the risk of radiation-induced lung toxicity.
    Wang J; Cao J; Yuan S; Ji W; Arenberg D; Dai J; Stanton P; Tatro D; Ten Haken RK; Wang L; Kong FM
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):798-804. PubMed ID: 22836048
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No clinically significant changes in pulmonary function following stereotactic body radiation therapy for early- stage peripheral non-small cell lung cancer: an analysis of RTOG 0236.
    Stanic S; Paulus R; Timmerman RD; Michalski JM; Barriger RB; Bezjak A; Videtic GM; Bradley J
    Int J Radiat Oncol Biol Phys; 2014 Apr; 88(5):1092-9. PubMed ID: 24661663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comprehensive analysis of pulmonary function Test (PFT) changes after stereotactic body radiotherapy (SBRT) for stage I lung cancer in medically inoperable patients.
    Stephans KL; Djemil T; Reddy CA; Gajdos SM; Kolar M; Machuzak M; Mazzone P; Videtic GM
    J Thorac Oncol; 2009 Jul; 4(7):838-44. PubMed ID: 19487961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Monte Carlo algorithm for compliance with RTOG 0915 dosimetric criteria in peripheral lung cancer patients treated with stereotactic body radiotherapy.
    Pokhrel D; Sood S; Badkul R; Jiang H; McClinton C; Lominska C; Kumar P; Wang F
    J Appl Clin Med Phys; 2016 May; 17(3):277-293. PubMed ID: 27167284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II Trial of SBRT for Stage I NSCLC: Survival, Local Control, and Lung Function at 36 Months.
    Navarro-Martin A; Aso S; Cacicedo J; Arnaiz M; Navarro V; Rosales S; de Blas R; Ramos R; Guedea F
    J Thorac Oncol; 2016 Jul; 11(7):1101-11. PubMed ID: 27103512
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in pulmonary function after incidental lung irradiation for breast cancer: A prospective study.
    Jaén J; Vázquez G; Alonso E; León A; Guerrero R; Almansa JF
    Int J Radiat Oncol Biol Phys; 2006 Aug; 65(5):1381-8. PubMed ID: 16757130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary function testing after stereotactic body radiotherapy to the lung.
    Bishawi M; Kim B; Moore WH; Bilfinger TV
    Int J Radiat Oncol Biol Phys; 2012 Jan; 82(1):e107-10. PubMed ID: 21470798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dosimetric predictors of radiation-induced lung injury in stereotactic body radiation therapy.
    Ricardi U; Filippi AR; Guarneri A; Giglioli FR; Mantovani C; Fiandra C; Anglesio S; Ragona R
    Acta Oncol; 2009; 48(4):571-7. PubMed ID: 19031164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predicting postoperative pulmonary function in patients undergoing lung resection.
    Zeiher BG; Gross TJ; Kern JA; Lanza LA; Peterson MW
    Chest; 1995 Jul; 108(1):68-72. PubMed ID: 7606994
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pulmonary function changes after radiotherapy in non-small-cell lung cancer patients with long-term disease-free survival.
    Borst GR; De Jaeger K; Belderbos JS; Burgers SA; Lebesque JV
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(3):639-44. PubMed ID: 15936539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in pulmonary function after three-dimensional conformal radiotherapy, intensity-modulated radiotherapy, or proton beam therapy for non-small-cell lung cancer.
    Lopez Guerra JL; Gomez DR; Zhuang Y; Levy LB; Eapen G; Liu H; Mohan R; Komaki R; Cox JD; Liao Z
    Int J Radiat Oncol Biol Phys; 2012 Jul; 83(4):e537-43. PubMed ID: 22420964
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact on Pulmonary Function in a Randomized Trial of Single-Fraction and Multifraction Stereotactic Body Radiation Therapy for Pulmonary Oligometastatic Disease: An Analysis of TROG 13.01 (SAFRON II).
    Bucknell NW; Hardcastle N; Bressel M; Moore A; Montgomery R; Murnane A; Mai GT; Ball D; Kron T; Siva S
    Int J Radiat Oncol Biol Phys; 2024 Mar; 118(4):944-951. PubMed ID: 37871885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic body radiotherapy for second primary lung cancer and intra-parenchymal lung metastasis in patients previously treated with surgery: evaluation of indications and predictors of decreased respiratory function.
    Ishihara T; Yamada K; Harada A; Yukiue H; Tanahashi M; Niwa H; Matsui T; Yokomura K; Ejima Y; Sasaki R
    Acta Oncol; 2018 Sep; 57(9):1232-1239. PubMed ID: 29722594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Initial report on feasibility of PET/CT-based image-guided moderate hypofractionated thoracic irradiation in node-positive non-small cell lung Cancer patients with poor prognostic factors and strongly diminished lung function: a retrospective analysis.
    Eze C; Taugner J; Roengvoraphoj O; Schmidt-Hegemann NS; Käsmann L; Wijaya C; Belka C; Manapov F
    Radiat Oncol; 2019 Sep; 14(1):163. PubMed ID: 31484542
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.